# US 2005/0233348 A1 · Protein fragment complementation assay (PCA) for the detection of protein-protein, protein-small molecule and protein nucleic acid interactions based on the E. coli TEM-1 beta-Lactamase

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2005/0233348 A1
- Document ID: US20050233348A1
- Status: Published application
- Kind: A1
- Application number: 11/002,259
- Filed: 2004-12-03
- Published: 2005-10-20
- Earliest claimed: 1998-02-02
- Assignees: Odyssey Thera, Inc.
- Inventors: Stephen William Michnick; Andre Galarneau
- Web page: https://patentgrep.com/patent/US20050233348A1

## CPC

- G01N 33/502: {for testing non-proliferative effects}
- C07K 14/43595: {from coelenteratae, e.g. medusae}
- C12N 15/1055: {Protein x Protein interaction, e.g. two hybrid selection}
- G01N 33/5008: {for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics}
- G01N 33/531: Production of immunochemical test materials
- G01N 33/58: involving labelled substances (G01N33/53 takes precedence)
- G01N 33/68: involving proteins, peptides or amino acids {(involving lipoproteins G01N33/92)}
- G01N 33/6845: {Methods of identifying protein-protein interactions in protein mixtures}
- G01N 2333/986: acting on amide bonds in cyclic amides (3.5.2), e.g. beta-lactamase (penicillinase, 3.5.2.6), creatinine amidohydrolase (creatininase, EC 3.5.2.10), N-methylhydantoinase (3.5.2.6)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The present invention describes an assay method comprising: (A) generating (1) at least a first fragment of a reporter molecule linked to a first interacting domain and at least a second fragment of a reporter molecule linked to a second interacting domain, or (2) nucleic acid molecules that code for (A)(1) and subsequently allowing said nucleic acid molecules to produce their coded products; then, (B) allowing interaction of said domains; and (C) detecting reconstituted reporter molecule activity, where said reporter molecule can react with a penicillin- or a cephalosporin-class substrate.

## Claims

### Claim at position 1

1-11. (canceled)

### Claim 12

An assay method comprising:
(A) exposing a host cell to:
1) at least a first fragment of a reporter molecule linked to a first interacting domain and at least a second fragment of a reporter molecule linked to a second interacting domain; or
2) compounds that code therefor; and
(B) detecting reconstituted reporter molecule activity, where a reporter molecule substrate is added that becomes trapped within said cell after entrance therein.

### Claim 13

An assay method comprising:
(A) exposing a host cell to:
1) at least a first fragment of a reporter molecule linked to a first interacting domain and at least a second fragment of a reporter molecule linked to a second interacting domain; or
2) compounds that code therefor; and
(B) detecting reconstituted reporter molecule activity, where a reporter molecule substrate is added that has a fluorescent signal-producing system covalently associated therewith.

### Claim 14 (depends on 13)

An assay according to claim 13 wherein cleavage of said substrate by said reporter molecule results in a change in fluorescent signal production.

### Claim 15 (depends on 12)

An assay according to claims 12, or 13 where a compound is added that leads to a detectable decrease in reporter molecule activity by decreasing interaction between interacting domains.

### Claim 16

An assay method comprising:
(A) exposing a host cell to:
1) at least a first fragment of a reporter molecule linked to a first interacting domain and at least a second fragment of a reporter molecule linked to a second interacting domain; or
2) compounds that code therefor; and
(B) detecting host cell survival as an indication of reconstituted reporter molecule activity.

### Claim 17

An assay method comprising:
(A) exposing a host cell to:
1) at least a first fragment of a reporter molecule linked to a first interacting domain and at least a second fragment of a reporter molecule linked to a second interacting domain; or
2) compounds that code therefor;
(B) further exposing said cell to a compound to be assayed for its ability to interfere with interaction of said first and second domains; and
(C) detecting host cell survival as an indication of interference with said interaction.

### Claim 18

A composition comprising a compound which comprises a fragment of an interacting domain linked to a fragment of a reporter molecule that catalyses the hydrolysis of the amide bond of β-lactam rings in penicillin or cephalosporin compounds.

### Claim 19

A composition comprising:
(A) a first compound comprising a first fragment of an interacting domain linked to a first fragment of a reporter molecule that catalyses the hydrolysis of the amide bond of β-lactam rings in penicillin or cephalosporin compounds; and
(B) a second compound comprising a second fragment of an interacting domain linked to a second fragment said reporter molecule.

### Claim 20 (depends on 18, 19)

A composition according to claim 18 or 19 where said reporter molecule is an enzyme.

### Claim 21 (depends on 18, 19)

A composition according to claim 18 or 19 where said reporter molecule is a β-lactamase.

### Claim 22 (depends on 18, 19)

A composition according to claim 18 or 19 where said interacting domain is derived from a leucine zipper or from a rapamycin-inducible interacting protein.

### Claim 23 (depends on 18, 19)

A composition according to claim 18 or 19 where said interacting domain is derived from a GCN 4 leucine zipper or from FKBP/FRB.

### Claim 24 (depends on 18, 19)

A composition according to claim 18 or 19 wherein at least one of said compounds has a flexible linker joining its reporter molecule fragment to its associated interacting domain.

### Claim 25 (depends on 18, 19)

A nucleic acid molecule comprising a sequence that codes for any of the compounds according to claim 18 or 19.

### Claim 26 (depends on 20)

A nucleic acid molecule comprising a sequence that codes for any of the compounds according to claim 20.

### Claim 27 (depends on 21)

A nucleic acid molecule comprising a sequence that codes for any of the compounds according to claim 21.

### Claim 28 (depends on 22)

A nucleic acid molecule comprising a sequence that codes for any of the compounds according to claim 22.

### Claim 29 (depends on 23)

A nucleic acid molecule comprising a sequence that codes for any of the compounds according to claim 23.

### Claim 30 (depends on 24)

A nucleic acid molecule comprising a sequence that codes for any of the compounds according to claim 24.

### Claim 31 (depends on 25)

A vector comprising any of the nucleic acids according to claim 25.

### Claim 32 (depends on 26)

A vector comprising any of the nucleic acids according to claim 26.

### Claim 33 (depends on 27)

A vector comprising any of the nucleic acids according to claim 27.

### Claim 34 (depends on 28)

A vector comprising any of the nucleic acids according to claim 28.

### Claim 35 (depends on 29)

A vector comprising any of the nucleic acids according to claim 29.

### Claim 36 (depends on 30)

A vector comprising any of the nucleic acids according to claim 30.

### Claim 37 (depends on 18, 19)

A cell in contact with any of the compounds according to claim 18 or 19 or with any molecule that codes for any of said compounds.

### Claim 38 (depends on 20)

A cell in contact with any of the compounds according to claim 20 or with any molecule that codes for any of said compounds.

### Claim 39 (depends on 21)

A cell in contact with any of the compounds according to claim 21 or with any molecule that codes for any of said compounds.

### Claim 40 (depends on 22)

A cell in contact with any of the compounds according to claim 22 or with any molecule that codes for any of said compounds.

### Claim 41 (depends on 23)

A cell in contact with any of the compounds according to claim 23 or with any molecule that codes for any of said compounds.

### Claim 42 (depends on 24)

A cell in contact with any of the compounds according to claim 24 or with any molecule that codes for any of said compounds.

### Claim at position 33

43-62. (canceled)
